XML 68 R50.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Common Stock, Compensation Plans and Other (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Summary of Stock Option Transactions under Plan | The table below summarized the stock option transactions under the Plan at December 31, 2024, 2023 and 2022 and changes during the years then ended:
| 2024 |  | 2023 |  | 2022
| Shares (000) |  | Weighted- average Exercisable Price |  | Shares (000) |  | Weighted- average Exercisable Price |  | Shares (000) |  | Weighted- average Exercisable Price
Outstanding, beginning of year | 2,776 |  |  | $ | 20.95 |  |  | 2,971 |  |  | $ | 20.45 |  |  | 3,015 |  |  | $ | 20.06 |
Granted | 10 |  |  | 29.41 |  |  | 25 |  |  | 22.63 |  |  | 183 |  |  | 21.13 |
Forfeited/Expired | (35) |  |  | 21.87 |  |  | (10) |  |  | 23.38 |  |  | (96) |  |  | 21.89 |
Exercised | (1,161) |  |  | 18.65 |  |  | (210) |  |  | 14.01 |  |  | (131) |  |  | 11.30 |
Outstanding, end of year | 1,590 |  |  | 22.66 |  |  | 2,776 |  |  | 20.95 |  |  | 2,971 |  |  | 20.45 |
Exercisable, end of year | 1,044 |  |  | 22.34 |  |  | 1,940 |  |  | 20.05 |  |  | 1,837 |  |  | 18.89 |
Summary of Stock Options on Valuation Assumptions | The assumptions used in determining the fair value of 2024, 2023 and 2022 stock option grants were as follows:
| For the Years Ended December 31,
| 2024 |  | 2023 | 2022
Expected dividend yield | 2.65 | % |  | 2.98 | % |  | 3.14 | %
Expected stock price volatility | 28.47 | % |  | 27.97 | % |  | 31.18 | %
Risk-free interest rate | 4.25 | % |  | 3.37 | % |  | 2.82 | %
Expected life of options | 6.5 years |  | 6.5 years |  | 6.5 years
Summary of Currently Outstanding and Exercisable Options | The following is a summary of currently outstanding and exercisable options at December 31, 2024:
Options Outstanding |  | Options Exercisable
Exercise Prices |  | Options Outstanding Shares (000) |  | Weighted- Average Remaining Contractual Life (in years) |  | Weighted- Average Exercise Price |  | Options Exercisable Shares (000) |  | Weighted- Average Exercise Price
$16.00 to $17.99 |  | 24 |  |  | 0.29 |  | $ | 17.12 |  |  | 24 |  |  | $ | 17.12 |
$18.00 to $19.99 |  | 118 |  |  | 1.32 |  | 18.57 |  |  | 118 |  |  | 18.57 |
$20.00 to $21.99 |  | 159 |  |  | 4.01 |  | 20.83 |  |  | 128 |  |  | 20.89 |
$22.00 to $23.99 |  | 1,221 |  |  | 3.66 |  | 23.22 |  |  | 735 |  |  | 23.18 |
$24.00 to $25.99 |  | 58 |  |  | 3.87 |  | 25.42 |  |  | 39 |  |  | 25.96 |
$26.00 to $27.99 |  | — |  |  | 0.00 |  | — |  |  | — |  |  | — |
$28.00 to $29.99 |  | 10 |  |  | 9.85 |  | 29.41 |  |  | — |  |  | — |
|  | 1,590 |  |  |  |  |  |  | 1,044 |  |  |
Summary of Company's Restricted Stock Issued and Outstanding | The table below summarizes the activity for the Company’s restricted stock issued and outstanding at December 31, 2024, 2023 and 2022 and changes during the years then ended:
| 2024 |  | 2023 |  | 2022
| (In thousands)
Beginning of year | 1,429 |  |  | 1,381 |  |  | 1,231 |
Issued | 531 |  |  | 261 |  |  | 409 |
Vested | (469) |  |  | (152) |  |  | (178) |
Forfeited | (62) |  |  | (61) |  |  | (81) |
End of year | 1,429 |  |  | 1,429 |  |  | 1,381 |
Amount of expense for twelve months ended | $ | 8,228 |  |  | $ | 8,016 |  |  | $ | 7,646 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration